PBMs, pharma companies avoid drug price transparency
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses ...
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses ...
In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis ...
This article first appeared in the newsletter Your Local Epidemiologist.Pharmaceutical ads in the United States are annoying. Absurd. And almost ...
WASHINGTON — President Trump directed health secretary Robert F. Kennedy Jr. to crack down on misleading direct-to-consumer drug advertisements in ...
When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
AI has quickly been moving through the pharmaceutical industry, where professionals are seeing clear value – from shortening the drug ...
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering ...
📖 Table of Contents Are you looking to gain muscle mass effectively and safely? Many people aim for muscle growth, ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.